Shanbao Li

745 total citations · 1 hit paper
19 papers, 526 citations indexed

About

Shanbao Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shanbao Li has authored 19 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shanbao Li's work include Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (4 papers) and Circular RNAs in diseases (4 papers). Shanbao Li is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (4 papers) and Circular RNAs in diseases (4 papers). Shanbao Li collaborates with scholars based in China, United States and Germany. Shanbao Li's co-authors include Junyong Weng, Zhonglin Zhu, Ruoxin Zhang, Yufei Yang, Xinxiang Li, Qi Liu, Junming Xu, Chao Xiao, Fangbin Song and Zhiwei Qin and has published in prestigious journals such as Frontiers in Immunology, Transplantation and Cancer Letters.

In The Last Decade

Shanbao Li

17 papers receiving 522 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploring immunotherapy in colorectal cancer

2022 219 citations Junyong Weng, Shanbao Li et al. Journal of Hematology & Oncology profile →

Peers

Shanbao Li

ONCOL

PRM

IMMUN

Junyong Weng China

Lu Zang China

Hai‐Yu Mo China

Hongbing Mei China

Anne Tranberg Madsen Denmark

Chandrika Jeyamohan United States

Wentao Tian China

Sun Mi Hong South Korea

Mengxue Yu China

Dengxiong Li China

Junyong Weng China

Shanbao Li

514 ×2.0

249 ×1.2

ONCOL

373 ×2.1

144 ×1.7

PRM

95 ×1.2

IMMUN

Citations per year, relative to Shanbao Li Shanbao Li (= 1×) peers Junyong Weng

Countries citing papers authored by Shanbao Li

Since Specialization

Citations

This map shows the geographic impact of Shanbao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanbao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanbao Li more than expected).

Fields of papers citing papers by Shanbao Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanbao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanbao Li. The network helps show where Shanbao Li may publish in the future.

Co-authorship network of co-authors of Shanbao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shanbao Li. A scholar is included among the top collaborators of Shanbao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanbao Li. Shanbao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Li, Shanbao, Junyong Weng, Jing Lu, et al.. (2025). TDO2 Deficiency Exacerbates the Immune Rejection Response in Rat Liver Transplantation via the Kyn-AHR Axis. Transplantation. 109(8). e386–e399.

Li, Lei, Shanbao Li, Fangbin Song, et al.. (2025). TTLL4 mediates the PI3K/AKT/MDM2 pathway to promote hepatocellular carcinoma progression and predict patient prognosis. APL Bioengineering. 9(2). 26128–26128.

Zhu, Zhonglin, et al.. (2024). LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3. Cancer Letters. 589. 216828–216828. 7 indexed citations

Li, Shanbao, et al.. (2023). Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro. Frontiers in Oncology. 13. 1159126–1159126. 5 indexed citations

Li, Shanbao, Junyong Weng, Chao Xiao, et al.. (2023). Cuproptosis‐related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features. Cancer Reports. 6(12). e1904–e1904. 6 indexed citations

Zhu, Zhonglin, Tianan Guo, Junyong Weng, et al.. (2023). Cuproptosis‐related miRNAs signature and immune infiltration characteristics in colorectal cancer. Cancer Medicine. 12(15). 16661–16678. 8 indexed citations

Li, Shanbao, et al.. (2022). Transcriptomic analysis of graft liver provides insight into the immune response of rat liver transplantation. Frontiers in Immunology. 13. 947437–947437. 3 indexed citations

Weng, Junyong, Shanbao Li, Zhonglin Zhu, et al.. (2022). Exploring immunotherapy in colorectal cancer. Journal of Hematology & Oncology. 15(1). 95–95. 219 indexed citations breakdown →

Li, Lei, Xuebin Qin, Tao Wang, et al.. (2022). Activation of the Aryl Hydrocarbon Receptor Ameliorates Acute Rejection of Rat Liver Transplantation by Regulating Treg Proliferation and PD-1 Expression. Transplantation. 106(11). 2172–2181. 8 indexed citations

10.

Li, Lei, Tao Wang, Shanbao Li, et al.. (2021). TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway. Frontiers in Oncology. 10. 562823–562823. 41 indexed citations

11.

Li, Shanbao, Lei Li, Fangbin Song, et al.. (2020). TDO Promotes Hepatocellular Carcinoma Progression. OncoTargets and Therapy. Volume 13. 5845–5855. 24 indexed citations

12.

Li, Shanbao, Junyong Weng, Fangbin Song, et al.. (2020). Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression. Cell Death and Disease. 11(6). 452–452. 37 indexed citations

13.

Weng, Junyong, Shanbao Li, Yang Liu, et al.. (2020). PCDHGA9 represses epithelial-mesenchymal transition and metastatic potential in gastric cancer cells by reducing β-catenin transcriptional activity. Cell Death and Disease. 11(3). 206–206. 12 indexed citations

14.

Xiao, Chao, Gang Wu, Zhijie Zhou, et al.. (2019). RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial–mesenchymal transition and promotes metastasis of colorectal cancer. Cell Death and Disease. 10(11). 833–833. 31 indexed citations

15.

Qin, Zhiwei, Zhengqian Chen, Junyong Weng, et al.. (2019). Elevated HOXA13 expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2. OncoTargets and Therapy. Volume 12. 1803–1813. 17 indexed citations

16.

Li, Shanbao, Junyong Weng, Lei Li, et al.. (2019). Circular RNA circZNF566 Promotes Hepatocellular Carcinoma Progression by Sponging miR-4738-3p and Regulating TDO2 Expression. SSRN Electronic Journal. 2 indexed citations

17.

Liu, Tingting, Xi-Sheng Liu, Meng Zhang, et al.. (2018). Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway. Journal of Cancer Research and Clinical Oncology. 144(6). 1049–1063. 56 indexed citations

18.

Weng, Junyong, Jingbo Xiao, Yushuai Mi, et al.. (2018). PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer. Cell Death and Disease. 9(2). 27–27. 41 indexed citations

19.

Song, Fangbin, Jianbing Zhang, Shanbao Li, et al.. (2017). ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy. OncoTargets and Therapy. Volume 10. 4859–4867. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact